GRAFT-VERSUS-HOST-DISEASE
Clinical trials for GRAFT-VERSUS-HOST-DISEASE explained in plain language.
Never miss a new study
Get alerted when new GRAFT-VERSUS-HOST-DISEASE trials appear
Sign up with your email to follow new studies for GRAFT-VERSUS-HOST-DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to make stem cell transplants safer for kids with leukemia
Disease control Not yet recruitingThis study tests new ways to make stem cell transplants safer and more effective for children and young adults with high-risk or relapsed acute lymphoblastic leukemia (ALL). It involves up to 1,000 participants aged 3 months to 25 years. The goal is to reduce life-threatening sid…
Matched conditions: GRAFT-VERSUS-HOST-DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
New study checks safety of JAKAVI for GVHD patients
Disease control Not yet recruitingThis study will check how safe and effective JAKAVI (ruxolitinib) is for patients with graft-versus-host disease (GVHD), a condition that can occur after a stem cell transplant. About 395 people will take part, and researchers will track infections and other side effects. The goa…
Matched conditions: GRAFT-VERSUS-HOST-DISEASE
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New study aims to unravel immune secrets of chronic GVHD
Knowledge-focused Not yet recruitingThis study looks at why some people develop chronic graft-versus-host disease (GVHD) after a stem cell transplant. Researchers will analyze immune cells in blood and affected tissues from 75 participants. The goal is to better understand the disease, not to test a new treatment.
Matched conditions: GRAFT-VERSUS-HOST-DISEASE
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:46 UTC